Weld Capital Management’s Allergan plc AGN Stock Holding History

Weld Capital Management’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-3,672	Closed	-$538K	–	1027
2019 Q1	$538K	Buy	+3,672	New	+$532K	0.1%	372

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Weld Capital Management's AGN Position: Q2 2019 in Review

Weld Capital Management sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 3,672 shares — an estimated $538K sold.

Weld Capital Management first reported a position in AGN in Q1 2019 and held it in 1 quarter. The position peaked at $538K in Q1 2019. 971 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

Weld Capital Management reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
Weld Capital Management sold 3,672 Allergan plc shares in Q2 2019, an estimated $538K.
Weld Capital Management first reported a position in Allergan plc in Q1 2019 and held it in 1 quarter.
Weld Capital Management's Allergan plc position peaked at $538K in Q1 2019.
971 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Weld Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.